Did you know?

ChinaBio® Group is a consulting and advisory firm helping life science companies and investors achieve success in China. ChinaBio works with U.S., European and APAC companies and investors seeking partnerships, acquisitions, novel technologies and funding in China.  

Learn more >>

Free Newsletter

Have the latest stories on China's life science industry delivered to your inbox daily or weekly - free!

See preview >>

  Email address:
   

VoxelCloud Raises $50 Million for AI-based Clinical Decision Support

publication date: Dec 18, 2018

VoxelCloud closed a $50 million Series B funding to support its AI-based automated medical image analysis and clinical decision support systems. Founded in 2015, VoxelCloud has offices in Los Angeles, Suzhou and Shanghai. The company believes its next-generation artificial intelligence and cloud computing -- along with first-class data -- will help realize its global goals. It currently offers automated reading of scans for lung cancer, retinal diseases, and coronary heart disease. More details....

Share this with colleagues:



Sorry this page is available to subscribers only.
If you're not a subscriber why not subscribe today?

If you are already a subscriber, please login.

If you believe you should have received this message in error, please contact us.


 

To gain access to the members only content click here to subscribe.

You will be given immediate access to premium content on the site.

ChinaBio® News

Greg Scott BIO-Europe Interview
Greg Scott Interviewed at BIO-Europe Spring

How to bring your China assets to China in 8 minutes

Greg Scott Mendelspod Interview
"Mr. Bio in China."
Mendelspod Interview

Multinational pharma held to a higher standard in China

Partner Event
November 2-3, 2023 | Shanghai
November 7-8, 2023 | Digital